AzTrials
AzTrials

Postoperative DeliriumPODprojectNCT06248684

Prevention of Postoperative Delirium in Elderly Patients

A study testing standardized prevention and therapy measures in people with Postoperative Delirium, run by Technical University of Munich.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Prevention of Postoperative Delirium in the care of Elderly Patients. A Monocentric, Prospective Intervention Study With the Question of Whether the Incidence, Length and Severity of Postoperative Delirium Can be Reduced by Implementing a Standardised, Multidimensional Delirium Management Protocol. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Postoperative Delirium
What is being tested?
standardized prevention and therapy measures
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15,000 participants
Where
No sites listed yet
Study dates
6 Feb 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • >= 65 Years
  • intervention in one of the following departments: general and visceral surgery, urology, vascular surgery, orthopedics, trauma surgery,
  • Written consent by patient or legal guardian

Who cannot join

  • Foreign language patients without interpreter
  • non-consenting patients without a legal representative

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Gerhard Prof. Dr. med. Schneider, MD contact

+49-89-41404291

AINS@mri.tum.de

Stefanie PD Dr. med. Pilge, MD contact

+49-89-41404291

AINS@mri.tum.de

About this study

Official title: Prevention of Postoperative Delirium in the Care of Elderly Patients. A Monocentric, Prospective Intervention Study

Prevention of Postoperative Delirium in the care of Elderly Patients. A Monocentric, Prospective Intervention Study With the Question of Whether the Incidence, Length and Severity of Postoperative Delirium Can be Reduced by Implementing a Standardised, Multidimensional Delirium Management Protocol.

Read the detailed description

Within the framework of a six-month observation period, the investigators intend to identify risk factors of the patient collective for the development of postoperative delirium. For this purpose, a preoperative risk assessment is performed, which includes cognitive and physical performance as well as premedication and concomitant diseases. Included are patients of at least 65 years of age of defined specialties. Postoperatively, patients who have undergone the assessment are tested for delirium once per shift until the third postoperative day and severity and duration are documented. After completion of the observation period, risk factors favoring the development of postoperative delirium will be identified. In the subsequent intervention period, patients from the age of 65 years with an additional identified risk factor will receive standardized, targeted perioperative care. This includes both adherence to preventive measures in accordance with guidelines and the recommendation of therapeutic measures if a delirium is diagnosed. Through the standardized, interprofessional and interdisciplinary application of the described approach, the investigator aim to reduce the incidence, duration and severity of postoperative delirium. Furthermore, the evaluation of the identification of the weighting of risk factors as well as the identification of risk factors by the tests performed, length of hospital stay, three-month mortality and daily living skills after three months. In addition, a baseline EEG (standardized awake EEG before initiation) is recorded in a subgroup to determine whether patients at risk for delirium can be identified and whether intraoperative EEG parameters support the delirium risk assessment.

Being tested
standardized prevention and therapy measures
Keywords
delirium, prevention and control, post operative delirium, delirium, risk factors, delirium, risk assessment, Baseline-EEG, cognitive tests, EEG, intraoperative
Medical subject headings
Emergence Delirium, Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standardized prevention and therapy measuresOther

    Patients from the age of 65 years with an additional risk factor for postoperative delirium are assigned to a multidimensional standardized perioperative care protocol.

Study groups in NCT06248684
Study groupRoleWhat they receive
prevention groupOtherpatients receive standardized perioperative care using Standard Operating Procedures (SOPs) in accordance with the guidelines of the professional societies for the prevention of postoperative delirium.
Receives: Other: standardized prevention and therapy measures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative delirium

    Patients are examined once per shift for the described duration postoperatively using validated tests for delirium (CAM-ICU or 3D-CAM). Delirium testing is supplemented by pain assessment using the numerical rating scale (NRS).

    Measured: for three days postoperatively and if the patient is delirium positive on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest

Secondary outcomes (8)
  1. duration of postoperative delirium

    Patients are examined once per shift for the described duration postoperatively using validated tests for delirium (CAM-ICU or 3D-CAM). Delirium testing is supplemented by pain assessment using the numerical rating scale (NRS).

    Measured: for three days postoperatively and if the patient has delirium on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest

  2. Severity of the postoperative delirium

    Patients are examined once per shift for the described duration postoperatively using validated tests for delirium severity (CAM-ICU or 3D-CAM). Delirium testing is supplemented by pain assessment using the numerical rating scale (NRS).

    Measured: for three days postoperatively and if the patient has delirium on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest

  3. Which parameters and tests detect patients at risk for postoperative delirium?

    analysis of the preoperative risk assessment, perioperative clinical parameters and postoperative delirium screening.

    Measured: From the time of premedication until three days postoperatively

  4. Can baseline and intraoperative EEG parameters be used to identify patients at risk? Does intraoperative burst suppression EEG represent a risk factor for delirium?

    Analysis of EEG data recorded immediately before induction of anesthesia and during surgery.

    Measured: From the patient's arrival in the operating room to three days postoperatively

  5. When is the diagnosis of postoperative delirium most commonly made?

    Patients are examined once per shift for the described duration postoperatively using validated tests for delirium (CAM-ICU or 3D-CAM). Delirium testing is supplemented by pain assessment using the numerical rating scale (NRS).

    Measured: for three days postoperative

  6. The implementation of a delirium management protocol during the intervention period serves to improve the three-month outcome of patients at risk in terms of maintaining their autonomy or daily living skills.

    Patients are asked about their daily living skills by telephone three months after their surgical procedure.

    Measured: One-time interview three months postoperatively

  7. Implementation of a delirium management protocol reduces the length of hospital stay of risk patients

    The length of inpatient stay of patients before and after implementation of standardized care is evaluated

    Measured: from the date of hospitalisation to the date of discharge from hospital, up to the day 90 visit at the latest

  8. Implementation of a delirium management protocol reduces three-month mortality in high-risk patients

    Three-month mortality of patients before and after implementation of standardized care is evaluated

    Measured: Query of the patients' death data three months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2024
  2. Study start6 Feb 2024 (estimated)
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06248684
Sponsor's protocol ID
Postoperative delirium project
Acronym
PODproject
Status last verified
Jan 2024
First submitted
1 Oct 2023
Last updated
8 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing standardized prevention and therapy measures in people with Postoperative Delirium, run by Technical University of Munich.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gerhard Prof. Dr. med. Schneider, MD (+49-89-41404291, AINS@mri.tum.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative delirium (time frame: for three days postoperatively and if the patient is delirium positive on the last day for the period until he is delirium negative or discharged from inpatient care, up to the day 90 visit at the latest). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in